Radcliffe Capital Management’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Radcliffe Capital Management’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-473,479	Closed	-$4.67M	–	1089
2022 Q3	$4.67M	Hold	473,479	–	–	0.11%	303
2022 Q2	$4.65M	Hold	473,479	–	–	0.11%	321
2022 Q1	$4.63M	Hold	473,479	–	–	0.11%	281
2021 Q4	$4.64M	Hold	473,479	–	–	0.12%	225
2021 Q3	$4.61M	Hold	473,479	–	–	0.13%	192
2021 Q2	$4.58M	Hold	473,479	–	–	0.14%	195
2021 Q1	$4.57M	Buy	+473,479	New	+$4.58M	0.18%	187

Radcliffe Capital Management's SHAC Position: Q4 2022 in Review

Radcliffe Capital Management sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 473,479 shares — an estimated $4.67M sold.

Radcliffe Capital Management first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $4.67M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Radcliffe Capital Management reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 473,479 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $4.67M.
Radcliffe Capital Management first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $4.67M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.